Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:805-812
Published online before print February 12, 2009, doi: 10.1161/CIRCRESAHA.108.189951
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v104,pe59)
Right arrow All Versions of this Article:
104/6/805    most recent
CIRCRESAHA.108.189951v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pound, K. M.
Right arrow Articles by Lewandowski, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pound, K. M.
Right arrow Articles by Lewandowski, E. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DICHLOROACETIC ACID
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Energy metabolism
Right arrow Heart failure - basic studies
Right arrow Hypertrophy
Right arrowRelated Article
(Circulation Research. 2009;104:805.)
© 2009 American Heart Association, Inc.


Integrative Physiology

Substrate–Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride Content

Attenuating Upregulated Anaplerosis in Hypertrophy

Kayla M. Pound, Natalia Sorokina, Kalpana Ballal, Deborah A. Berkich, Mathew Fasano, Kathryn F. LaNoue, Heinrich Taegtmeyer, J. Michael O'Donnell, E. Douglas Lewandowski

From the Program in Integrative Cardiac Metabolism (K.M.P., N.S., M.F., J.M.O., E.D.L.), Center for Cardiovascular Research, University of Illinois at Chicago, College of Medicine; Department of Internal Medicine (K.B., H.T.), Division of Cardiology, University of Texas Houston Medical School, Houston; and Department of Molecular and Cellular Physiology (D.A.B., K.F.L.), Pennsylvania State University Medical School, Hershey.

Correspondence to E. Douglas Lewandowski, PhD, Department of Physiology and Biophysics, MC 901, UIC College of Medicine, 835 S Wolcott Ave, Chicago, IL 60612. E-mail dougl{at}uic.edu

Recent work identifies the recruitment of alternate routes for carbohydrate oxidation, other than pyruvate dehydrogenase (PDH), in hypertrophied heart. Increased carboxylation of pyruvate via cytosolic malic enzyme (ME), producing malate, enables "anaplerotic" influx of carbon into the citric acid cycle. In addition to inefficient NADH production from pyruvate fueling this anaplerosis, ME also consumes NADPH necessary for lipogenesis. Thus, we tested the balance between PDH and ME fluxes in hypertrophied hearts and examined whether low triacylglyceride (TAG) was linked to ME-catalyzed anaplerosis. Sham-operated (SHAM) and aortic banded rat hearts (HYP) were perfused with buffer containing either 13C-palmitate plus glucose or 13C glucose plus palmitate for 30 minutes. Hearts remained untreated or received dichloroacetate (DCA) to activate PDH and increase substrate competition with ME. HYP showed a 13% to 26% reduction in rate pressure product (RPP) and impaired dP/dt versus SHAM (P<0.05). DCA did not affect RPP but normalized dP/dt in HYP. HYP had elevated ME expression with a 90% elevation in anaplerosis over SHAM. Increasing competition from PDH reduced anaplerosis in HYP+DCA by 18%. Correspondingly, malate was 2.2-fold greater in HYP than SHAM but was lowered with PDH activation: HYP=1419±220 nmol/g dry weight; HYP+DCA=343±56 nmol/g dry weight. TAG content in HYP (9.7±0.7 µmol/g dry weight) was lower than SHAM (13.5±1.0 µmol/g dry weight). Interestingly, reduced anaplerosis in HYP+DCA corresponded with normalized TAG (14.9±0.6 µmol/g dry weight) and improved contractility. Thus, we have determined partial reversibility of increased anaplerosis in HYP. The findings suggest anaplerosis through NADPH-dependent, cytosolic ME limits TAG formation in hypertrophied hearts.


Key Words: anaplerosis • cardiac hypertrophy • triglycerides


Related Article:

Innate Short-Circuiting of Mitochondrial Metabolism in Cardiac Hypertrophy: Identification of Novel Consequences of Enhanced Anaplerosis
Michael N. Sack
Circ. Res. 2009 104: 717-719. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
Z. Lu, I. Scott, B. R. Webster, and M. N. Sack
The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology
Circ. Res., October 23, 2009; 105(9): 830 - 841.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. N. Sack
Innate Short-Circuiting of Mitochondrial Metabolism in Cardiac Hypertrophy: Identification of Novel Consequences of Enhanced Anaplerosis
Circ. Res., March 27, 2009; 104(6): 717 - 719.
[Full Text] [PDF]